SynPhNe adopts telehealth to ensure continual therapy to their patients
-
- SynPhNe starts online therapy sessions for patients affected with stroke and other neuromuscular disorders to ensure continual improvement even during lockdown
- COVID-19 and lockdown provides impetus to telemedicine and telehealth
Mumbai, May 6th, 2020: The COVID-19 pandemic has left a large number of patients suffering from Neuromuscular disorders such as stroke, traumatic brain injuries (TBI), Parkinson’s disease and learning disabilities (LD) in a precarious condition because of a sudden loss of access to therapy.
To cater to the needs of these patients, SynPhNe, a digital neurological therapeutics company, has adopted telehealth initiatives to provide virtual therapy/online sessions to their patients. Based on the assessment of the patient’s past and current condition, a trained therapist from SynPhNe guides them through an exercise routine that has been specially customised considering the improvement goals that are mutually set.
Stroke is one of the leading causes of disability in India. People who survive a stroke suffer from acute to severe functional movement and cognition-related disorders. Many stroke survivors find difficulties in activities of daily living (ADLs) such as eating with their own hands, maintaining personal hygiene, wearing clothes by themselves, etc. These patients require continual and prolonged therapy to improve function and to prevent regression.
Many stroke patients have comorbidities such as diabetes, hypertension, etc., which necessitates performing some level of physical exercise; the online sessions help address this need as well. The patients suffering from cognition deficit are asked to do tasks like reading, writing the alphabet, doing a simple puzzle, etc.
Emphasising the importance of online sessions, Abhijeet Pandit, director and chief executive officer, SynPhNe India Pvt Ltd, VP Global Network Dev. & Marketing, says “The current and future need is to adopt telehealth and telemedicine in delivering care and therapy to our patients. Since the lockdown, we have initiated, with great success, online consulting and therapy. SynPhNe technology has been made commercially available on two platforms – the SynPhNe Xpert (for franchisees, hospitals and clinics) and the SynPhNe eNabl (for home users). In the current scenario, post-lockdown, depending upon the requirement, the patients can either purchase or rent the device and use it at home with the SynPhNe therapists monitoring their progress online with the help of the data being generated during every therapy session.
“We see an increasing trend of patients wanting to maintain social distancing even after the lockdown is lifted and therefore, going forward, SynPhNe will move aggressively to convince the patients to adopt SynPhNe technology at home. Post-lockdown, for patients who prefer to visit SynPhNe Care centres, we will offer our patients a combination of offline and online sessions, as per their preference. The online sessions will essentially supplement what we do offline.”
About SynPhNe Pte.
Founded in 2014 in Singapore, SynPhNe has its corporate headquarters in Singapore and two subsidiaries, one in Mumbai, India and second in New Jersey, US. SynPhNe is the world’s first medical device that trains brain and muscle as one system helping patients to restore their functional capabilities and cognition post stroke. It aims to make the patient independent again.
The company’s mission is to develop technologies which restore the first line of treatment and cure for chronic disability and disease.
For more information, visit: http://www.synphne.in/
Media Contact
| Name | Contact No | Email Id |
| Ritika Dutt | +91 9820910855 | ritika.dutt@spag.asia |
| Meeral Salia | +91 7738364559 | meeral.salia@spag.asia |
Read more from the Health Issues India press office here.
